peer comparison on financials
4dx -
revenue - 0.000 for quarter end 30th sep 2020
Net cash from operating activities- (4.459 million ) Loss
PYC
revenue- 0.0000 for quarter end 30th sep2020
Net Cash from operating activities ( 3.603 million ) Loss
RHT
revenue - $940,000 for quarter end 30th sep 2020
Net Cash from Operating activities-$450,000 profit and profitable from last two years
it's very important to note that RHT management is spending every dollar carefully and doing research and development much better than its peers and still only fraction of its peers in terms of MC.
- Forums
- ASX - By Stock
- why RHT should be a $1.00 now
RHT
resonance health limited
Add to My Watchlist
0.00%
!
4.0¢

peer comparison on financials 4dx - revenue - 0.000 for quarter...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.38M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 460 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 75743 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 460 | 0.040 |
1 | 50000 | 0.039 |
4 | 1621198 | 0.038 |
1 | 200000 | 0.037 |
3 | 167501 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 75743 | 2 |
0.049 | 128357 | 2 |
0.050 | 42423 | 3 |
0.053 | 56066 | 1 |
0.055 | 60000 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
RHT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online